AADI

Aadi Bioscience (AADI)

Aadi Bioscience Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AADI

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/20	05 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2024/09/06	06 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/09/04	06 : 51	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:AADI	Aadi Bioscience Inc
2024/09/03	23 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/08/23	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2024/08/21	10 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2024/08/21	06 : 00	PR Newswire (US)	Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates	NASDAQ:AADI	Aadi Bioscience Inc
2024/08/08	05 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AADI	Aadi Bioscience Inc
2024/08/07	21 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2024/08/07	21 : 00	PR Newswire (US)	Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/08/06	07 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/08/01	05 : 05	PR Newswire (US)	Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/06/15	05 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/06/15	05 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/06/15	05 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/06/15	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/06/15	05 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/06/13	05 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2024/06/06	05 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/06/04	01 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/30	05 : 05	PR Newswire (US)	Aadi Bioscience to Participate in the Jefferies Healthcare Conference	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/24	06 : 30	PR Newswire (US)	Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/09	05 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/08	21 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/08	21 : 00	PR Newswire (US)	Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/01	21 : 01	PR Newswire (US)	Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/04/09	21 : 00	PR Newswire (US)	Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/17	21 : 00	PR Newswire (US)	Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/13	21 : 00	PR Newswire (US)	Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/06	22 : 00	PR Newswire (US)	Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc